Happy to share our latest paper w/ @SibaElHussein as lead author, out today in @BMTjournal ⚡️Acquired WT1 mutations contribute to relapse of NPM1mut AML following allogeneic hematopoietic stem cell transplant  rdcu.be/cEuxv #hemepath #leukemia #hemepathMDA Image
WT1 mutations are present in ~7% of de novo AML, are typically Lof mutation involving exons 7-9 of the gene. They frequently (~15%) co-occur w/ NPM1mut & have detrimental impact in this setting, shown by @AkEisfeld and colleagues in  bit.ly/3eWQtXw @LeukemiaJnl Image
We studies a cohort of de novo NPM1-mut AML. 7% had concurrent WT1 mutations at baseline.  22% (15/67) relapsed; 4 (27%) with newly acquired Lof WT1-mut. Illustrated by @furudateken Image
Most interestingly 3/4 were post allo-HSCT (2 w/ matched related; 1 matched unrelated donors). WT1 mutations were both clonal and subclonal. Illustrated by @furudateken Image
The exact role of WT1-mut in leukemogenesis is unknown. We know WT1-mut are typically mutually exclusive with TET2-mut, suggesting overlapping function.
This was shown in the TCGA cohort and ECOG E1900 cohort by @RossLevineLab bit.ly/3t7AU7A @NEJM
Wild type WT1 protein overexpression is seen in in >70 % of AML, and is believed to have immunogenic effects, shown previously by @lab_rezvani and colleagues bit.ly/3HJC25n @BloodJournal Image
Wild type WT1 maintains early HCS progenitor cells in a quiescent state while promoting differentiation of more mature lineage-committed progenitor cells, its postnatal expression is limited to gonads, podocytes of kidney and mesothelial cells. Illustrated by @SibaElHussein Image
LoF WT1 mutations are thought to interfere with this immunogenicity, and escape from host immune system.
haematologica.org/article/view/8…
Our findings suggest that emerging WT1 mutations may serve as a conduit for relapse in NPM1-mut AML, particularly post-HSCT, & that evaluation for emergent WT1 mutations, particularly at relapse has value in the surveillance of patients with NPM1 mutated AML. #bmtsm #leusm
A lot remains unknown re the role WT1-mut in AML and we are excited to dive deeper and learn more, so stay tuned.   
Major gratitude to all our co-authors, especially @SibaElHussein @furudateken , @DrKTakahashi , @SaWangMD , and the Twiterless but incredible Courtney DiNardo!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Sanam Loghavi, MD 🔬🧬

Sanam Loghavi, MD 🔬🧬 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @sanamloghavi

8 Jan
The story of 1 day in the life of a #hematopathologist… I’m too exhausted to make a fancy educational thread but here are some amazing 🔬 pics for your viewing pleasure. I diagnosed all cases in one day 🤯 only at @MDAndersonNews Happy almost weekend people 🥂 #hemepath 🧵 1/n Image
Myeloproliferative neoplasm w/ concurrent BCR::ABL1 and JAK2 V617F ..the megekaryocyte morphology is clue to something beyond CML #mpnsm #PathOutPic 2/ ImageImageImage
BPDCN with perfect so-called “hand mirror” (red) and “pearl necklace” (black) morphology #BPDCN #PathOutPic 3/ Image
Read 11 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(